Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term phlegm-resolving activity describes the therapeutic process—mainly in traditional Chinese medicine—by which agents promote the reduction, dissolution, and clearance of phlegm from the respiratory tract. This principle is central to symptom management for diseases causing excessive or pathologic mucus production, such as infections, allergies, and chronic lung diseases[1][3][4][5][6]. Agents with phlegm-resolving activity may function as expectorants (thinning or hydrating mucus to facilitate elimination), anti-inflammatories, or modifiers of respiratory secretions. While these treatments may provide symptomatic relief, “phlegm-resolving activity” itself is not a single molecular target, receptor, or druggable entity, but rather a mechanistic category encompassing various pharmacological and non-pharmacological interventions[1][4][6].
Increasing hydration and thinning of mucus; Promoting expectoration (coughing out mucus); Modulating mucosal secretions (some TCM formulas claim to act on systemic “phlegm”)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phlegm-resolving activity.